Nerina Denaro

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Paolo Bossi, Rosalba Miceli, Laura D. Locati et al. · Annals of Oncology · 2017 · 80 citations

Medicine, Pathology, First-line Treatment +5

Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer

Marco Merlano, Martino Monteverde, Ida Colantonio et al. · Oral Oncology · 2012 · 54 citations

Adaptive Radiotherapy, Neck Cancer, Radiation Therapy +8

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Laura Lattanzio, Nerina Denaro, Daniela Vivenza et al. · Cancer Immunology Immunotherapy · 2017 · 49 citations · Full text

Neck Cancer, Radiation Therapy, Medicine +8

Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression

Matteo Paccagnella, Andrea Abbona, Andrea Michelotti et al. · Vaccines · 2022 · 32 citations · Full text

Breast Oncology, Immunology, Immunoediting +19

Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective.

Nerina Denaro, Marco Merlano, Elvio Russi et al. · PubMed · 2014 · 29 citations